Insider Trading July 1, 2026 04:22 PM

CNO Financial CEO Gary Bhojwani Liquidates $4.43M in Shares Post-Option Exercise

Executive divestment follows strong year-to-date performance and recent analyst upgrade, with valuation metrics suggesting caution for institutional positioning.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
CNO

CNO Financial Group, Inc. (NASDAQ:CNO) CEO Gary C. Bhojwani executed a significant divestment of company equity on June 30, 2026, liquidating approximately $4.43 million in common stock. The transaction followed the exercise of employee stock options and occurred as shares approached their 52-week high, raising questions regarding executive timing relative to current valuation metrics and recent fundamental upgrades.

CNO Financial CEO Gary Bhojwani Liquidates $4.43M in Shares Post-Option Exercise
CNO
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO Gary Bhojwani liquidated $4.43 million in CNO stock following option exercises, executed via a pre-arranged Rule 10b5-1 plan adopted in March 2026.
  • The divestment occurred near the stock's 52-week high of $53.03, despite recent Q1 2026 earnings beating estimates and a price target upgrade from Evercore ISI.
  • The transaction impacts the insurance sector, particularly long-term care and financial services, where executive selling near valuation highs may signal caution to institutional investors.

Gary C. Bhojwani, serving as both Chief Executive Officer and a board director for CNO Financial Group, Inc. (NASDAQ:CNO), executed a substantial divestment of company equity on June 30, 2026. The transaction involved the sale of common stock totaling approximately $4.43 million. This liquidation activity followed the exercise of employee stock options, through which Mr. Bhojwani acquired shares valued at approximately $931,905. The timing of these sales coincided with CNO shares trading near their 52-week high of $53.03, a level reached following a robust 34% gain over the preceding 12 months. Market analysis indicates the stock currently trades slightly above its Fair Value estimate, positioning it among companies identified as potentially overvalued relative to intrinsic metrics.

Documentation submitted in the Form 4 filing reveals that Mr. Bhojwani acquired 44,250 shares of CNO common stock at a price of $21.06 per share through the option exercise. These specific options had vested in two equal tranches on February 23, 2019, and February 23, 2020, respectively, and carry an expiration date of February 23, 2027.

Immediately subsequent to the acquisition, Mr. Bhojwani disposed of a total of 86,048 shares of common stock. These divestitures were executed pursuant to a Rule 10b5-1 trading plan, which was formally adopted on March 31, 2026. The shares were liquidated across two distinct transactions:

  • 44,250 shares were sold at a weighted average price of $51.4759 per share.
  • 41,798 shares were sold at a weighted average price of $51.4773 per share.

The sale prices for both transactions ranged from $50.98 per share to $52.13 per share. Following these transactions, Mr. Bhojwani directly holds 174,264 shares of CNO common stock. Additionally, he indirectly holds 651,189 shares through the Gary C. Bhojwani Revocable Trust.

In recent operational developments, CNO Financial Group reported strong earnings for the first quarter of 2026. Earnings per share reached $1.05, surpassing the forecasted $0.94. The company’s revenue also exceeded expectations, coming in at $1.03 billion compared to the anticipated $1.01 billion. Furthermore, Evercore ISI upgraded CNO Financial’s stock rating from Underperform to In Line, raising its price target to $48 from $43. This upgrade was based on a long-term care statutory analysis that highlighted strong underlying performance within its peer group.

Additionally, CNO Financial Group held its annual meeting of shareholders, where nine directors were elected to serve one-year terms. Each nominee received significant support, with at least 80 million votes in favor. These developments reflect recent progress and strategic decisions within the company.

Risks

  • CNO Financial Group trades slightly above its Fair Value estimate, suggesting potential overvaluation that could lead to mean reversion if fundamentals do not sustain current multiples.
  • The execution of a Rule 10b5-1 plan, while standard for compliance, may obscure the true timing of executive sentiment relative to the stock's recent 34% annual gain.
  • Regulatory scrutiny of executive compensation and stock sales in the insurance sector remains elevated, particularly when coupled with rapid price appreciation and upgrade cycles.

More from Insider Trading

Marvell Technology Executive Chris Koopmans Executes $2.82 Million Stock Sale Under 10b5-1 Plan Jul 1, 2026 Hershey Trust Affiliate Reduces Equity Position Amidst Leadership and Credit Rating Shifts Jul 1, 2026 Cornelius Prior Jr. Offloads $138,235 in ATN International Equity Jul 1, 2026 American Well Officer Executes Mandatory Share Sale Amid Stock Rally Jul 1, 2026 CoreCivic's Executive Insider Activity and Recent Corporate Developments Jul 1, 2026